top of page

Metabolomics Improves 10-Year Cardiovascular Risk Prediction in Type 2 Diabetes

  • Feb 24
  • 0 min read
Graphical abstract showing UK Biobank/ESTHER cohorts, sex-specific metabolite selection, and C-index gains from adding NMR markers to SCORE2-Diabetes.

 
 
logo02_edited.png

California NanoSystems Institute

570 Westwood Plaza
Bldg 114, Rm 6350H, Mail 722710
Los Angeles, California 90095‐7227

Copyright © 2025

Dalton Bioanalytics Inc.

Subscribe to Our Newsletter

Thanks for subscribe!

bottom of page